The effect of the coq5-4 mutation is similar to a null, since it results in a stop codon at position 93. However, the coq5-3 mutation (G 304 D) is located just four amino acids away from the carboxyl-terminus. While C-methyltransferase activity is detectable in mitochondria isolated from this mutant, the steady state level of Coq5p is dramatically decreased. These studies show that at least two functions can be attributed to Coq5p; first, it is required to catalyze the Cmethyltransferase step in Q biosynthesis and second, it is involved in stabilizing the Coq3 and Coq4 polypeptides required for Q biosynthesis.
INTRODUCTION
the CYC1 promoter in pUE3 as described. The 1.86 kb BamHI / Kpn1 fragment of pS5PE1 was inserted into pRS426 to generate pM5PE1, a multi-copy version of pS5PE1.
Sequence Analysis DNA segments containing the protein coding region, and 5'-and 3'-flanking regions of COQ5 alleles were produced by PCR amplification of genomic DNA from yeast strains CH83-B1 (coq5-2), CH256-3A (coq5-3), CH259-5D (coq5-4), and CH316-6B (coq5-5). The 5' primer pBCOQ5 (5'-CCGTGATACTATCGGCGATA-3') corresponded to position -400 to -380, and the 3' primer pTCOQ5 (5'-TGGCTATCACATGGCACAGG-3') corresponded to +1040 to +1020 relative to the +1 position of the COQ5 coding region. DNA sequence analysis of the PCR product was performed as described previously (13) .
Generation of Antisera Against Coq5p and Western Blot Analysis A segment of the
COQ5 ORF (+91 to +924) encompassing the predicted mature Coq5p was amplified with the primers pHF5 (+91 to +113; 5'-GAAGATCTCAAAGAAGAAGAAGTTAATAGTC-3') and pHR5 (+924 to +896; 5'-GAAGATCTTTAAAVTTTAATGCCCCAATG-3'). An approximately 0.83 kb fragment of COQ5 ORF was digested with BglII and inserted into the BglII site of the expression vector pTrcHisB (Invitrogen) to generate pTHQ5-1. A fusion protein containing a 6-His tag at the N-terminus was overexpressed in the E. coli strain DH5α. Expression of the recombinant Coq5p was induced with 1 mM IPTG at 37 °C and continued for 3 hours. For purification of Coq5p, harvested cells were resuspended in 5 mM imidazole, 0.5 M NaCl, 20 mM Tris-HCl, pH 7.9 buffer containing 6 M urea and cells were disrupted by five freeze-thaw cycles and sonicated. The supernatant obtained after a 1 h centrifugation at 12,000 rpm was applied to a Ni (II)-NTA column (Qiagen). The column was washed with buffer (as above, but containing 20 mM imidazole), and the recombinant Coq5p was eluted with 250 mM imidazole in the above buffer containing 6 M urea. The 6His-Coq5 fusion protein was further purified by 15% SDS-PAGE and transferred to an Immobilon P membrane. The electrophoretically pure preparation of the fusion protein was eluted from the membrane and used to generate antiserum in rabbits (Cocalico biologicals, Inc., Reamstown, PA). The specificity of the antiserum was confirmed by immunoblotting against mitochondria from a wild type strain and a strain containing coq5::HIS3 disruption allele. Western blot analysis was carried out as described (24).
The primary antibodies were used at the following dilutions: anti-Coq3p, 1:2000; anti-Coq5p, 8 matrix fractions were separated by 15% SDS-PAGE and after transfer to nitrocellulose were subjected to Western blot analysis.
In Vitro C-Methyltransferase Assay Assays of C-methyltransferase activity were performed with 2-farnesyl-6-methoxy-1,4-benzoquinol (compound 3, Fig. 1 ) as substrate to a final concentration of 50 µM (14). The assay was modified so that reactions were similar to those described for the γ-tocopherol methyltransferases (28) . Each reaction mixture (500 µl) contained 50 mM tricine-NaOH, pH 7.5, 1 mM MgCl 2 , 0. Ci/mmol) and incubated at 37 °C for 1 hour. Assays performed under these conditions with wild-type mitochondria showed linear rates of product formation. Reactions were stopped by addition of 5 µl glacial acetic acid and oxidized with 25 µl fresh 1% ammonium cerium (IV) nitrate. Lipids were extracted with 2 ml 1:2 (v:v) chloroform:methanol and 500 µl 0.9% (w:v) NaCl and centrifuged at 2500 rpm for 5 min. The organic layer was transferred to a new tube and dried under nitrogen gas, separated by HPLC and assayed for radioactivity (22).
In Vitro O-Methyltransferase Assay-Protein concentration was determined with the BCA assay (Pierce) with BSA as a standard. Assays of O-methyltransferase activity were performed with 3,4-dihydroxy-5-farnesylbenzoic acid (compound 1, Fig. 1 ) or 2-farnesyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinol (compound 5, Fig. 1 ) as substrate (29) . The corresponding farnesylated analogs of methylated products (compounds 2 and 6, Fig. 1 under nitrogen. HPLC and assays for radioactivity were performed as described above.
RNA Isolation and Northern Analysis  Total RNA was isolated from the yeast strains listed in Table 1 . Yeast were grown in YPGal media and harvested in mid-log phase (OD 600 = 1.0). RNA was isolated by the hot phenol method as described (30 transformation with pHUE3-1, a multi-copy version of pUE3, and when ubiE was expressed from the yeast COQ5 promoter, present on either single copy (pS5PE1) or multi-copy (pM5PE1) plasmids (Table II) . Conversely, each of the coq5 mutants is rescued when transformed with plasmids containing the yeast COQ5 gene (Table II) .
Complementation analysis of coq5 mutants Complementation analysis was carried out
with the yeast coq5 mutant strains. As shown in Table 3 , diploids resulting from the mating of coq5-3 and coq5-2, or coq5-3 and coq5-5 mutants, were able to grow on YPG media, while diploids produced in all other crosses were defective for growth on YPG. These results suggest that at least two categories of coq5 mutant alleles are present in the panel of coq5 mutants: one that is defective in the C-methyltransferase step (and can be rescued by E. coli ubiE), and another that is defective in a secondary function of Coq5p. polypeptide is located only four residues away from the carboxyl terminus. It seems less likely that C-methyltransferase activity of coq5-3 would be impaired, consistent with the interpretation of the complementation analysis, suggesting that the coq5-3 polypeptide retains Cmethyltransferase activity. However, the coq5-3 mutation does result in a respiratory deficient phenotype, indicating that some other function of Coq5p is being compromised.
Sequence Analysis of coq5 Mutant Alleles

Assays of Methyltransferase Activity in Mitochondria Isolated From the coq5 Mutants 
In vitro C-methyltransferase activity of Coq5p was assayed with the farnesylated analog of compound 3 (Fig. 1 
) and S-adenosyl-L-[methyl-
3 H]methionine. Mitochondria from wild-type yeast produced a radioactive product that co-migrated with the DMQ 3 product standard on reverse phase HPLC ( Fig. 4A; fraction 8) . No activity was detected in mitochondria isolated from the coq5 strain. Assays were similarly performed with mitochondria isolated from the different coq5 mutant strains. Only the coq5-3 mutant had detectable C-methyltransferase activity (Fig. 4B) . The amount of C-methyltransferase activity present in mitochondria isolated from the coq5-3 mutant was rather variable, ranging from 30 to 75 percent of wild type. A representative result is presented in Fig. 4B .
In vitro O-methyltransferase activity of Coq3p was assayed with the farnesylated analogs of either compound 1 or 5 ( Fig. 1 ). Essentially no activity was detected in mitochondria isolated from coq5 yeast with either of the farnesylated substrate analogs ( Previous assays have shown that assays of yeast Coq3 O-methyltransferase activity is much greater with the farnesylated analog of compound 5 as compared to compound 1 (29) .
Significantly, very low levels of O-methyltransferase activity were present in mitochondria isolated from either the coq5-3 or coq5-4 mutants (Fig. 5B ). These data indicate that a subset of the coq5 mutants, coq5-2 and coq5-5, retain O-methyltransferase activity, while only the coq5-3 mutant retains C-methyltransferase activity.
Submitochondrial Localization of Coq5 Polypeptide
To determine the submitochondrial localization of Coq5p, yeast mitochondria were further fractionated, and
Coq5p was monitored with an antibody specific for yeast Coq5p. Purified mitochondria from wild-type yeast were subjected to treatment with hypotonic buffer, which disrupts the outer membrane while keeping the inner membrane intact, followed by sonication, releasing soluble matrix proteins into the supernatant after centrifugation. Western blot analysis of submitochondrial fractions indicated that Coq5p remained associated with the membrane fractions, along with the integral membrane protein, cytochrome c 1 , while the soluble components of the intermembrane space, CCPO, or mitochondrial matrix, Mge1p, were released into the supernatant (Fig. 6A ).
To determine whether Coq5p associates with the outer or inner mitochondrial membrane, mitoplasts generated by hypotonic swelling of purified mitochondria were subjected to treatment with proteinase K in the presence and absence of the detergent Triton X-100. Coq5p was protected from proteolysis in intact mitochondria and mitoplasts, as was Mge1p, a soluble protein of the mitochondrial matrix, while cytochrome b 2 , a soluble intermembrane space polypeptide, was readily digested (Fig. 6B) . Only a disruption of membrane structure with Triton X-100 rendered Coq5p protease sensitive. However, contrary to cytochrome c 1 , Coq5p is efficiently solubilized after alkaline treatment of whole mitochondria (Fig. 6C) likely to be defective in C-methyltransferase activity since the mutation in each lies in or near a methyltransferase motif, respectively. Indeed, direct measurements of C-methyltransferase activity in mitochondria prepared from our panel of coq5 mutant strains revealed that only coq5-3 mitochondria exhibited an appreciable amount of C-methyltransferase activity (Fig. 4) .
Interestingly, the amino acid substitution in coq5-2 recapitulates that found in the ubiE401 mutant (G 142 D) and affects a conserved glycine residue thought to be critical for substrate binding (13) . The amino acid substitution present in the Coq5-3 polypeptide (G 304 D) is located four amino acids away from the carboxyl terminus. The phenotype of this mutant is very interesting; in mating studies, the coq5-3 mutant strain complements the coq5-2 and coq5-5 mutants for growth on glycerol, yet the coq5-3 mutant is respiratory deficient on its own.
Two O-methyltranferase steps occur in coenzyme Q biosynthesis and Coq3p catalyzes both. In coq5-3, coq5-4 and coq5 mutants, O-methyltransferase activity is drastically reduced (Fig. 5 ), in agreement with western blot analysis showing a loss of Coq3 polypeptide in these two mutants (Fig. 7) . Interestingly, a similar loss of Coq4 polypeptide is observed in the coq5-3, coq5-4, and coq5 mutants (Fig. 7) . A low level of Coq5 polypeptide is detected in the coq5-3 mutant, and this mutant is able to grow on YPG after 10 days at 30 °C, suggesting the presence of a low level of C-methyltransferase activity. This activity was indeed detected in the Cmethyltransferase assay of mitochondria isolated from the coq5-3 mutant strain. However, this low level of Coq5 polypeptide appears to be insufficient for detectable Coq3 activity (Fig. 5) or
Coq3 or Coq4 polypeptide stability (Fig. 7) . Coq3, Coq4, and Coq5 polypeptide levels are comparable to wild type in only the coq5-2 and coq5-5 mutants. These data indicate that stable, but catalytically inactive Coq5p, is sufficient for the expression of stable and active Coq3p.
Thus, at least two functions can be attributed to Coq5p; first, it is required to catalyze the Cmethyltransferase step in Q biosynthesis, and second, it is involved in stabilizing Coq3p and Coq4p required for coenzyme Q biosynthesis. The stabilizing effect of Coq5p may be mediated by the C-terminus of the polypeptide, since the glycine affected by the mutation coq5-3 is highly conserved (Fig. 3 ).
To better understand the level of regulation of COQ5 gene expression, Northern blot analysis was carried out on total RNA isolated from the yeast coq5 mutant panel. The COQ5
promoter contains consensus sites for Mig1, Rtg1/2/3 and Hap2/3/4; these factors are involved in regulating COQ5 expression depending on carbon source (34) . In the present study we have found the level of COQ5 RNA was not decreased in the coq5-3 mutant. Thus the decrease in Coq5-3p must be due to post-transcriptional control. Such post-transcriptional control must also account for the decreased levels of Coq3p and Coq4p in the coq5-3, coq5-4, and coq5 mutants, as steady state levels of COQ3 and COQ4 mRNAs show little change in response to the type of coq5 mutation (Fig.8 ).
In 
